Issue navigation
Volume 17, Issue suppl_7, July 2002
European Best Practice Guidelines for Haemodialysis (Part 1)
Frontmatter
Foreword
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 1, https://doi.org/10.1093/ndt/17.suppl_7.1
Introduction
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 2, https://doi.org/10.1093/ndt/17.suppl_7.2
Guideline development
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 3–4, https://doi.org/10.1093/ndt/17.suppl_7.3
Abbreviations
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 5–6, https://doi.org/10.1093/ndt/17.suppl_7.5
SECTION I: Measurement of renal function, when to refer and when to start dialysis
I.1 Measurement of renal function
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 7–9, https://doi.org/10.1093/ndt/17.suppl_7.7
I.2 When to refer to a nephrology clinic
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 9–10, https://doi.org/10.1093/ndt/17.suppl_7.9
I.3 When to start dialysis
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 10–11, https://doi.org/10.1093/ndt/17.suppl_7.10
I.4 Measurement of residual renal function in HD
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 11–14, https://doi.org/10.1093/ndt/17.suppl_7.11
Appendix I
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 14–15, https://doi.org/10.1093/ndt/17.suppl_7.14
Appendix II
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 15, https://doi.org/10.1093/ndt/17.suppl_7.15
SECTION II: Haemodialysis adequacy
II.1 Haemodialysis dose quantification: small solutes
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 17–21, https://doi.org/10.1093/ndt/17.suppl_7.17
II.2 Haemodialysis dose quantification: middle molecules (MM)
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 21–23, https://doi.org/10.1093/ndt/17.suppl_7.21
II.3 Haemodialysis dose and residual renal function (Kr)
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 24, https://doi.org/10.1093/ndt/17.suppl_7.24
II.4 Monitoring of treatment
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 24–25, https://doi.org/10.1093/ndt/17.suppl_7.24-a
II.5 Dialysis schedules
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 25–31, https://doi.org/10.1093/ndt/17.suppl_7.25
SECTION III: Biocompatibility
III.1 Biochemical reactions subsequent to complement and leukocyte activation
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 32–34, https://doi.org/10.1093/ndt/17.suppl_7.32
III.2 Clinical morbidity and mortality in response to complement and leukocyte activation
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 34–37, https://doi.org/10.1093/ndt/17.suppl_7.34
III.3 Spallation/release
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 37, https://doi.org/10.1093/ndt/17.suppl_7.37
III.4 Reactions to membranes and other dialyzer‐related material
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 37–38, https://doi.org/10.1093/ndt/17.suppl_7.37-a
III.5 Shear stress/haemolysis
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 38–44, https://doi.org/10.1093/ndt/17.suppl_7.38
SECTION IV: Dialysis fluid purity
IV.1 Water treatment system
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 45–46, https://doi.org/10.1093/ndt/17.suppl_7.45
IV.2 Technical design of the water treatment system
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 46–47, https://doi.org/10.1093/ndt/17.suppl_7.46
IV.3 Water treatment monitoring and maintenance
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 47–49, https://doi.org/10.1093/ndt/17.suppl_7.47
IV.4 Haemodialysishyphen;proportioning machine
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 49–50, https://doi.org/10.1093/ndt/17.suppl_7.49
IV.5 Electrolytic concentrates
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 50–51, https://doi.org/10.1093/ndt/17.suppl_7.50
IV.6 Dialysis fluid purity: implications in the haemocompatibility network system
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 51–54, https://doi.org/10.1093/ndt/17.suppl_7.51
Appendix: Water purification methods
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 54–61, https://doi.org/10.1093/ndt/17.suppl_7.54
Appendix: Quality assurance process
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 60–62, https://doi.org/10.1093/ndt/17.suppl_7.60
SECTION V: Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system
V.1 Haemodialysis and prevention of system clotting
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 63, https://doi.org/10.1093/ndt/17.suppl_7.63
V.2 Prevention of clotting in the HD patient with normal bleeding risk
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 64–66, https://doi.org/10.1093/ndt/17.suppl_7.64
V.3 Prevention of clotting in the HD patient with elevated bleeding risk
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 66–67, https://doi.org/10.1093/ndt/17.suppl_7.66
V.4 Heparin‐induced thrombocytopenia
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 67, https://doi.org/10.1093/ndt/17.suppl_7.67
V.5 Side effects of heparin
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 67–71, https://doi.org/10.1093/ndt/17.suppl_7.67-a
SECTION VI: Haemodialysis-associated infection
VI.1 Prevention of infection: management of impairment of the host defence
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 73–74, https://doi.org/10.1093/ndt/17.suppl_7.73
VI.2 Prevention of infection: management of host colonization by Staphylococcus aureus
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 74–75, https://doi.org/10.1093/ndt/17.suppl_7.74
VI.3 Prevention of infection: management of the vascular access
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 75–76, https://doi.org/10.1093/ndt/17.suppl_7.75
VI.4. Treatment of vascular access infection
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 76–77, https://doi.org/10.1093/ndt/17.suppl_7.76
VI.5 Prevention and management of TB in HD patients
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 77–78, https://doi.org/10.1093/ndt/17.suppl_7.77
VI.6 Prevention and management of HBV, HCV and HIV in HD patients
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 78–81, https://doi.org/10.1093/ndt/17.suppl_7.78
VI.7 Vaccine recommendations for patients on chronic HD (except HB vaccination)
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 81–87, https://doi.org/10.1093/ndt/17.suppl_7.81
SECTION VII: Vascular disease and risk factors
VII.1 Assessment of cardiovascular risk factors
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Page 88, https://doi.org/10.1093/ndt/17.suppl_7.88
VII.2 Dyslipidaemia
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 88–95, https://doi.org/10.1093/ndt/17.suppl_7.88-a
VII.3 Hyperphosphataemia and calcium‐phosphorus ion product
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 95–96, https://doi.org/10.1093/ndt/17.suppl_7.95
VII.4 Emerging risk factors
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 96–100, https://doi.org/10.1093/ndt/17.suppl_7.96
VII.5 Microinflammatory state
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 100–109, https://doi.org/10.1093/ndt/17.suppl_7.100
Backmatter
Biographical notes
Nephrology Dialysis Transplantation, Volume 17, Issue suppl_7, July 2002, Pages 110–111, https://doi.org/10.1093/ndt/17.suppl_7.110
